A retrospective analysis of nonresponse to denosumab after hip fractures
Acta Orthopaedica Belgica · 2023
DOI: 10.52628/89.1.9808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica Belgica, 2023. Verfasst von S J Kim und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, Bone Density Conservation Agents, Osteoporosis, Osteoporotic Fractures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Denosumab is an effective antiresorptive drug commonly prescribed for the treatment of osteoporosis. However, some patients do not respond well to denosumab treatment. The aim of this study was to evaluate the factors underlying treatment nonresponses to denosumab in elderly patients following hip fracture. This retrospective study included 130 patients treated with denosumab after osteoporotic hip fracture between March 2017 and March 2020. The patients were categorized as denosumab nonresponders if they had a T-score 3% decrease in bone mineral density (BMD), or an incident fracture on denosumab therapy. We examined the baseline characteristics associated with blunted BMD responses and compared the groups following denosumab treatment for 12 months. Of 130 patients with baseline data, 105 patients (80.8%) were considered responders. No difference in baseline vitamin D, calcium, BMI, age, gender, prior fracture history, or bisphosphonate use was observed between responders and nonresponders. A longer interval between denosumab injections was associated with suboptimal BMD response at both spine and total hip (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Kim, S. J., & Lee, D. W. (2023). A retrospective analysis of nonresponse to denosumab after hip fractures. Acta Orthopaedica Belgica. https://doi.org/10.52628/89.1.9808
Vancouver
Kim SJ, Lee DW. A retrospective analysis of nonresponse to denosumab after hip fractures. Acta Orthopaedica Belgica. 2023. doi:10.52628/89.1.9808
BibTeX
@article{Kim2023,
author = {Kim, S J and Lee, D W},
title = {A retrospective analysis of nonresponse to denosumab after hip fractures},
journal = {Acta Orthopaedica Belgica},
year = {2023},
doi = {10.52628/89.1.9808}
}
EUVIMED